$VICR

Davies Philip D sold $33K of VICR

Davies Philip D (VP Global Sales & Marketing) sold 100 shares of VICOR CORP (VICR) at $329.52 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jun 2, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Insider selling disclosures can influence short-term sentiment, but 10b5-1 plans generally reduce interpretability as a directional signal.

02

Market read

Traders may note the sale for sentiment/positioning, but there is no new fundamental information to drive a major repricing.

03

What to watch

The trade size is small relative to typical market liquidity, and the filing does not include any new guidance, contract, or earnings information.

Relevance 6/10Novelty 6/10Timing: Today’s SEC Form 4 filing (filed 2026-06-02) following the 2026-06-01 sale.

Background

The article reports a single SEC Form 4 insider transaction for Vicor Corp: an open-market sale by an officer/director under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCORP disclosed an insider open-market sale by VP Global Sales & Marketing Philip D. Davies under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited and short-lived.

Evidence & confidence

Form 4 shows a small, pre-arranged 10b5-1 sale (100 shares) with no accompanying company-specific operational or financial update.

Market effects

Minimal; this is company-specific insider activity with no sector-wide read-across provided.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale often reflects planned liquidity rather than bearish expectations, so the market may overreact if it treats it as a signal.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • Philip D. Davies

    VP Global Sales & Marketing who sold 100 shares on 2026-06-01 under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: